A. Hilary Calvert

Expert consensus on best content of a robotic surgical curriculum: a systematic review

Anna K. Kieslich, Ruari Jardine, Hussain Ibrahim, A. Hilary Calvert et autres

gb (code pays fourni par la source)

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

A. Hilary Calvert, David R. Newell, Lindsey Gumbrell, Séamus O’Reilly et autres

Discovering selective anticancer drugs: Succeeding slowly is better than failing fast

A. Hilary Calvert

gb (code pays fourni par la source)

Design and conduct of early clinical studies of two or more targeted anticancer therapies: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies

Lesley Seymour, A. Hilary Calvert, Marinus W. Lobbezoo, Elizabeth A. Eisenhauer et autres

bd, ca, gb, us (code pays fourni par la source)

Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies

Marinus W. Lobbezoo, A. Hilary Calvert, Elizabeth A. Eisenhauer, Giuseppe Giaccone

Nucleoside Transport Inhibitors: Structure−Activity Relationships for Pyrimido[5,4-d]pyrimidine Derivatives That Potentiate Pemetrexed Cytotoxicity in the Presence of α1-Acid Glycoprotein

Kappusamy Saravanan, Hannah Barlow, Marion Barton, A. Hilary Calvert et autres

gb (code pays fourni par la source)

Expression of folate receptor alpha (FRa) in malignant pleural mesothelioma patients by immunohistochemistry: a clinico-pathological analysis

Albiruni Ryan Abdul Razak, J E Nutt, K O’Toole, Fiona Black et autres

Phase 0 clinical trials: Recommendations from the task force on methodology for the development of innovative cancer therapies

Shivaani Kummar, James H. Doroshow, Joseph E. Tomaszewski, A. Hilary Calvert et autres

us (code pays fourni par la source)

Endpoints and other considerations in phase I studies of targeted anticancer therapy: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT)

Christopher M. Booth, A. Hilary Calvert, Giuseppe Giaccone, Marinus W. Lobbezoo et autres

ca, us (code pays fourni par la source)

Design and conduct of phase II studies of targeted anticancer therapy: Recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT)

Christopher M. Booth, A. Hilary Calvert, Giuseppe Giaccone, Marinus W. Lobbezoo et autres

ca, us (code pays fourni par la source)

Temozolomide Pharmacodynamics in Patients with Metastatic Melanoma: DNA Damage and Activity of Repair Enzymes O6-Alkylguanine Alkyltransferase and Poly(ADP-Ribose) Polymerase-1

Elizabeth Ruth Plummer, Mark R. Middleton, Christopher J. Jones, Anna L Olsen et autres

gb (code pays fourni par la source)

Design, Synthesis, and Evaluation of 3,4-Dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as Inhibitors of Poly(ADP-Ribose) Polymerase

Jayashree Tikhe, Stephen E. Webber, Zdeněk Hostomský, Karen A. Maegley et autres

gb (code pays fourni par la source)